Abera Bioscience AB Stock
Stocks
ABERA
SE0015245097
Biotechnology & Medical Research
OTC Markets Traded|
End-of-day quote
NORDIC GROWTH MARKET
2026-09-30
|
5-day change | 1st Jan Change | ||
| 6.860 SEK | +1.48% |
|
-.--% | +0.88% |
| 11-04 | Abera Bioscience gets go-ahead for Phase 1 study of pneumococcal vaccine | FW |
| 10-14 | Preclinical data for Abera Bioscience's pneumococcal vaccine published in scientific journal | FW |
| Market Cap | 141M 14.04M 12.69M 11.72M 10.6M 20.01M 1.32B 20.61M 55.88M 705M 52.68M 51.55M 2.25B | P/E 2024 |
-64.4x | P/E 2025 | -10.8x |
|---|---|---|---|---|---|
| Enterprise Value | 117M 11.69M 10.57M 9.76M 8.83M 16.67M 1.1B 17.17M 46.55M 588M 43.88M 42.94M 1.87B | EV / Sales 2024 |
4.32x | EV / Sales 2025 | 8.6x |
| Free-Float |
40.83% | Yield 2024 * |
-
| Yield 2025 | - |
NORDIC GROWTH MARKETSEK
| Markets | Quality | ||
|---|---|---|---|
NORDIC GROWTH MARKET
| ABERA | End-of-day quote | |
Deutsche Boerse AG
| 8WK | Delayed | |
|
Deutsche Boerse AG
| 8WK | End-of-day quote |
| 1 day | +1.48% | ||
| 3 months | -18.91% | ||
| 6 months | +3.63% | ||
| Current year | +0.88% |
| Current year | 5.15 |  | 10.05 |
| 1 year | 5.15 | | 10.05 |
| 3 years | 3.51 | | 10.05 |
| 5 years | 3.05 | | 21.5 |
| 10 years | 3.05 | | 30.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
Maria Alriksson
CEO | Chief Executive Officer | 43 | 2020-09-30 |
Joen Luirink
CTO | Chief Tech/Sci/R&D Officer | 66 | 2012-11-02 |
| Chief Tech/Sci/R&D Officer | 61 | 2022-04-30 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 56 | 2014-12-31 | |
Fredrik Juserius
BRD | Director/Board Member | 59 | 2019-12-31 |
| Director/Board Member | 74 | 2019-12-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 1/21/22 | Buy | Chairman | 12,000 | 0.1147% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.48% | -.--% | +14.33% | +52.44% | 14.09M | |
| +1.10% | +1.03% | +62.53% | +70.47% | 67.53B | |
| +1.28% | +8.71% | +13.96% | +92.70% | 60.74B | |
| +0.36% | -0.95% | +20.09% | +98.45% | 55.66B | |
| +0.21% | +8.60% | +11.41% | +111.49% | 47.97B | |
| -1.35% | +2.26% | +22.63% | +39.86% | 45.24B | |
| -1.49% | -0.01% | +169.85% | +804.02% | 39.08B | |
| +1.21% | +4.75% | +27.30% | +52.81% | 35.34B | |
| -0.87% | -2.89% | +79.60% | +56.33% | 33.45B | |
| -1.72% | +9.23% | -38.89% | +397.07% | 26.49B | |
| Average | +0.00% | +2.37% | +38.28% | +177.56% | 41B | |
| Weighted average by Cap. | +0.06% | +2.88% | +41.30% | +166.98% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 14.63M 1.46M 1.32M 1.22M 1.1M 2.08M 137M 2.14M 5.81M 73.38M 5.48M 5.36M 234M | 11.85M 1.18M 1.07M 987K 894K 1.69M 111M 1.74M 4.71M 59.45M 4.44M 4.34M 189M |
| Net income | -1.1M -110K -99.28K -91.64K -82.95K -157K -10.32M -161K -437K -5.52M -412K -403K -17.56M | -10.45M -1.04M -943K -871K -788K -1.49M -98.08M -1.53M -4.15M -52.43M -3.92M -3.83M -167M |
| Net Debt | -6.09M -608K -550K -507K -459K -867K -57.14M -893K -2.42M -30.55M -2.28M -2.23M -97.24M | -23.49M -2.34M -2.12M -1.96M -1.77M -3.34M -220M -3.44M -9.33M -118M -8.8M -8.61M -375M |
Employees
6
Net sales - Rate of surprise
- Stock Market
- Stocks
- ABERA Stock
Select your edition
All financial news and data tailored to specific country editions
